SCHEMBL8285168

SCHEMBL8285168

CCCc1c(F)cnc2c1c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.42
GSK3B P49841 3/20 0.36
CDK4 P11802 4/20 0.35
CCND1 P24385 4/20 0.35
CCND2 P30279 4/20 0.35
CCND3 P30281 4/20 0.35
ALDH1A1 P00352 5/20 0.35
CYP1A2 P05177 4/20 0.35
HPGD P15428 4/20 0.35
CYP3A4 P08684 3/20 0.35
MEN1 O00255 3/20 0.35
USP2 O75604 3/20 0.35
CYP2D6 P10635 3/20 0.35
CASP1 P29466 3/20 0.35
CASP7 P55210 3/20 0.35
KMT2A Q03164 3/20 0.35
HSD17B10 Q99714 3/20 0.35
HIF1A Q16665 2/20 0.35
ALOX15 P16050 2/20 0.35
BRCA1 P38398 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285162 0.92 PDE11A (0.43) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8285170 0.84 PDE11A (0.46) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8287128 0.81 CDK4 (0.36) PDE11ACDK4CCND1CCND2CCND3
SCHEMBL8285222 0.81 PDE11A (0.41) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8285209 0.80 PDE11A (0.43) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8287158 0.79 PDE11A (0.41) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8285192 0.79 PDE11A (0.42) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8287202 0.78 PDE11A (0.39) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8287378 0.77 PDE11A (0.38) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8286060 0.76 PDE11A (0.46) PDE11AGSK3BCDK4CCND1CCND2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed